Clinical Trial Update: EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating EF5 as an imaging agent to detect tumor hypoxia in patients with cervical, endometrial, or ovarian cancers undergoing surgery or biopsy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• EF5

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Primary Peritoneal Cavity Cancer, Stage I Endometrial Carcinoma | Phase 2 | Status: COMPLETED